Clinical Trial Update: TRACK-TBI Precision Medicine Part 3 - Option II [Phase 2]

View source ↗

Summary

This is an update on TRACK-TBI Precision Medicine Part 3 - Option II, a Phase 2 trial for traumatic brain injury that is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: University of California, San Francisco | Conditions: Traumatic Brain Injury | Phase 2 | Status: ENROLLING_BY_INVITATION